AMA-37

Modify Date: 2024-01-21 08:08:46

AMA-37 Structure
AMA-37 structure
Common Name AMA-37
CAS Number 404009-46-7 Molecular Weight 283.32200
Density N/A Boiling Point N/A
Molecular Formula C17H17NO3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of AMA-37


AMA-37, an Arylmorpholine analog, is ATP-competitive DNA-PK inhibitor, with IC50 values of 0.27 μM (DNA-PK), 32 μM (p110α), 3.7 μM (p110β), and 22 μM (p110γ), respectively[1][2].

 Names

Name (2-hydroxy-4-morpholin-4-ylphenyl)-phenylmethanone
Synonym More Synonyms

 AMA-37 Biological Activity

Description AMA-37, an Arylmorpholine analog, is ATP-competitive DNA-PK inhibitor, with IC50 values of 0.27 μM (DNA-PK), 32 μM (p110α), 3.7 μM (p110β), and 22 μM (p110γ), respectively[1][2].
Related Catalog
Target

IC50: 0.27 μM (DNA-PK)[1].

In Vitro AMA-37 inhbits PI3K poorly[2]. AMA-37 (20 μM) reduces the ability of UCN-01, isogranulatimide, and debromohymenialdesine, but not caffeine, to overcome G2 arrest (ρ < 0.05)[3]. Inhibition of DNA-PK with AMA37 leads to radiosensitization[3].
References

[1]. Zachary A Knight, et al. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell. 2006 May 19;125(4):733-47.

[2]. Zachary A Knight, et al. Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold. Bioorg Med Chem. 2004 Sep 1;12(17):4749-59.

[3]. Christopher M Sturgeon, et al. Effect of combined DNA repair inhibition and G2 checkpoint inhibition on cell cycle progression after DNA damage. Mol Cancer Ther. 2006 Apr;5(4):885-92.

 Chemical & Physical Properties

Molecular Formula C17H17NO3
Molecular Weight 283.32200
Exact Mass 283.12100
PSA 49.77000
LogP 2.52480
Storage condition -20℃

 Synonyms

AMA37
ArylMorpholine Analog 37
1-(2-Hydroxy-4-morpholin-4-yl-phenyl)-phenyl-methanone
DNA-PK Inhibitor V